BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Up 361.4% in July

BioNexus Gene Lab Corp. (NASDAQ:BGLC) saw a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 38,300 shares, agrowthof361.4% from the June 30th total of 8,300 shares. Based on an average trading volume of 1,040,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately3.3% of the shares of the company are short sold. Approximately3.3% of the shares of the company are short sold. Based on an average trading volume of 1,040,000 shares, the days-to-cover ratio is currently 0.0 days.

BioNexus Gene Lab Trading Up 2.6%

Shares of BGLC stock opened at $6.64 on Tuesday. BioNexus Gene Lab has a 1 year low of $2.01 and a 1 year high of $15.60. The stock has a fifty day moving average of $4.45 and a two-hundred day moving average of $3.60.

BioNexus Gene Lab (NASDAQ:BGLC) last announced its quarterly earnings data on Thursday, May 15th. The company reported ($0.03) earnings per share for the quarter. BioNexus Gene Lab had a negative net margin of 22.85% and a negative return on equity of 24.18%.

Analyst Ratings Changes

Separately, Wall Street Zen lowered BioNexus Gene Lab to a “strong sell” rating in a research report on Friday, May 30th.

About BioNexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.